Matthijs M. Versteegh: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Psychometric evaluation of the Dutch translation of the Overall Assessment of the Speaker's Experience of Stuttering for adults (OASES-A-D)

Caroline Koedoot, Matthijs Versteegh, J. Scott Yaruss

Journal:

Journal of Fluency Disorders

Year:

2011

Language:

english

File:

PDF, 177 KB

english, 2011

2

When is it too expensive? Cost-effectiveness thresholds and health care decision-making

Brouwer, Werner, van Baal, Pieter, van Exel, Job, Versteegh, Matthijs

Journal:

The European Journal of Health Economics

Year:

2018

Language:

english

File:

PDF, 766 KB

english, 2018

3

Dutch Tariff for the Five-Level Version of EQ-5D

M. Versteegh, Matthijs, M. Vermeulen, Karin, M. A. A. Evers, Silvia, de Wit, G. Ardine, Prenger, Rilana, A. Stolk, Elly

Journal:

Value in Health

Year:

2016

Language:

english

File:

PDF, 955 KB

english, 2016

4

Can time heal all wounds? An empirical assessment of adaptation to functional limitations in an older population

de Hond, Anne, Bakx, Pieter, Versteegh, Matthijs

Journal:

Social Science & Medicine

Year:

2019

Language:

english

File:

PDF, 1.17 MB

english, 2019

5

A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending

van Baal, Pieter, Perry-Duxbury, Meg, Bakx, Pieter, Versteegh, Matthijs, van Doorslaer, Eddy, Brouwer, Werner

Journal:

Health Economics

Year:

2018

Language:

english

File:

PDF, 1.18 MB

english, 2018

6

Summarizing Patient Preferences for the Competitive Landscape of Multiple Sclerosis Treatment Options

Jonker, Marcel F., Donkers, Bas, Goossens, Lucas M.A., Hoefman, Renske J., Jabbarian, Lea J., de Bekker-Grob, Esther W., Versteegh, Matthijs M., Harty, Gerard, Wong, Schiffon L.

Journal:

Medical Decision Making

Year:

2020

Language:

english

File:

PDF, 2.85 MB

english, 2020

7

Which factors may determine the necessary and feasible type of effectiveness evidence? A mixed methods approach to develop an instrument to help coverage decision-makers

de Groot, Saskia, Rijnsburger, Adriana J, Versteegh, Matthijs M, Heymans, Juanita M, Kleijnen, Sarah, Redekop, W Ken, Verstijnen, Ilse M

Journal:

Year:

2015

Language:

english

File:

PDF, 967 KB

english, 2015

8

LEAD TIME TTO: LEADING TO BETTER HEALTH STATE VALUATIONS?

Arthur E. Attema, Matthijs M. Versteegh, Mark Oppe, Werner B. F. Brouwer, Elly A. Stolk

Journal:

Health Economics

Year:

2012

Language:

english

File:

PDF, 168 KB

english, 2012

9

WOULD YOU RATHER BE ILL NOW, OR LATER?

Attema, Arthur E., Versteegh, Matthijs M.

Journal:

Health Economics

Year:

2013

Language:

english

File:

PDF, 191 KB

english, 2013

10

Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis

Versteegh, Matthijs

Journal:

PharmacoEconomics

Year:

2016

Language:

english

File:

PDF, 674 KB

english, 2016

11

From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare

Versteegh, Matthijs, Knies, Saskia, Brouwer, Werner

Journal:

PharmacoEconomics

Year:

2016

Language:

english

File:

PDF, 384 KB

english, 2016

12

Comparing the effectiveness and cost-effectiveness of self-management interventions in four high-priority chronic conditions in Europe (COMPAR-EU): a research protocol

Ballester, Marta, Orrego, Carola, Heijmans, Monique, Alonso-Coello, Pablo, Versteegh, Matthijs MichaÃ«l, Mavridis, Dimitri, Groene, O, Immonen, Kaisa, Wagner, Cordula, Canelo-Aybar, Carlos, Sunol, Ros

Journal:

Year:

2020

File:

PDF, 1.50 MB

2020

13

Mapping onto Eq-5 D for patients in poor health

Matthijs M Versteegh, Donna Rowen, John E Brazier, Elly A Stolk

Journal:

Health and Quality of Life Outcomes

Year:

2010

Language:

english

File:

PDF, 490 KB

english, 2010

14

Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma

Arnold, David T, Rowen, Donna, Versteegh, Matthijs M, Morley, Anna, Hooper, Clare E, Maskell, Nicholas A

Journal:

Health and Quality of Life Outcomes

Year:

2015

Language:

english

File:

PDF, 658 KB

english, 2015

15

Severity-Adjusted Probability of Being Cost Effective

Versteegh, Matthijs M., Ramos, Isaac Corro, Buyukkaramikli, Nasuh C., Ansaripour, Amir, Reckers-Droog, Vivian T., Brouwer, Werner B. F.

Journal:

PharmacoEconomics

Year:

2019

Language:

english

File:

PDF, 842 KB

english, 2019

16

Estimating Informal Caregiving Time from Patient EQ-5D Data: The Informal CARE Effect (iCARE) Tool

Gheorghe, Maria, Hoefman, Renske J., Versteegh, Matthijs M., van Exel, Job

Journal:

PharmacoEconomics

Year:

2018

Language:

english

File:

PDF, 1.25 MB

english, 2018

17

Are Health State Valuations from the General Public Biased? A Test of Health State Reference Dependency Using Self-assessed Health and an Efficient Discrete Choice Experiment

Jonker, Marcel F., Attema, Arthur E., Donkers, Bas, Stolk, Elly A., Versteegh, Matthijs M.

Journal:

Health Economics

Year:

2016

Language:

english

File:

PDF, 472 KB

english, 2016

18

Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model

Franken, Mira D., de Hond, Anne, Degeling, Koen, Punt, Cornelis J. A., Koopman, Miriam, Uyl-de Groot, Carin A., Versteegh, Matthijs M., van Oijen, Martijn G. H.

Journal:

Health and Quality of Life Outcomes

Year:

2020

File:

PDF, 696 KB

2020

19

An assessment of the external validity of mapping QLQ-C30 to EQ-5D preferences

Ralph Crott, Matthijs Versteegh, Carin Uyl-de-Groot

Journal:

Quality of Life Research

Year:

2013

Language:

english

File:

PDF, 336 KB

english, 2013

20

Introducing the composite time trade-off: a test of feasibility and face validity

Bas M. F. Janssen, Mark Oppe, Matthijs M. Versteegh, Elly A. Stolk

Journal:

The European Journal of Health Economics

Year:

2013

Language:

english

File:

PDF, 402 KB

english, 2013

21

Time to tweak the TTO: results from a comparison of alternative specifications of the TTO

Matthijs M. Versteegh, Arthur E. Attema, Mark Oppe, Nancy J. Devlin, Elly A. Stolk

Journal:

The European Journal of Health Economics

Year:

2013

Language:

english

File:

PDF, 336 KB

english, 2013

22

Cost-Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines

Ramos, Isaac Corro, Versteegh, Matthijs M., de Boer, Rudolf A., Koenders, Jolanda M.A., Linssen, Gerard C.M., Meeder, Joan G., Rutten-van Mölken, Maureen P.M.H.

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 1.42 MB

english, 2017

23

Time trade-off: one methodology, different methods

Arthur E. Attema, Yvette Edelaar-Peeters, Matthijs M. Versteegh, Elly A. Stolk

Journal:

The European Journal of Health Economics

Year:

2013

Language:

english

File:

PDF, 239 KB

english, 2013

24

Condition-Specific Preference-Based Measures: Benefit or Burden?

Matthijs M. Versteegh, Annemieke Leunis, Carin A. Uyl-de Groot, Elly A. Stolk

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 754 KB

english, 2012

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски